• OPEN AN ACCOUNT
Indian Indices
Sensex
73,123.83 -125.56
( -0.17%)
Global Indices
Nasdaq
52,230.09 -658.89
(-1.25%)
Dow Jones
7,644.13 -40.30
(-0.52%)
Hang Seng
62,584.98 -322.86
(-0.51%)
Nikkei 225
10,670.63 -54.40
(-0.51%)
Forex
USD-INR
94.61 0.10
(0.11%)
EUR-INR
106.18 0.08
(0.07%)
GBP-INR
126.70 0.19
(0.15%)
JPY-INR
0.60 0.00
(0.70%)

EQUITY - MARKET SCREENER

Colinz Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
531210
INE923C01011
39.8678099
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
33.42
17
EPS(TTM)
Face Value()
Div & Yield %
2.02
10
0
 

Indegene director resigns
Oct 15,2026
Indegene announced that Mark Francis Dzialga (DIN: 00955485) vide his letter dated 14 October 2026 has tendered his resignation from the position of Non-Executive - Non Independent Director of the Company, with effect from close of business hours of October 29, 2026, due to sale of the entire shareholding in the Company held by Brighton Park Capital and its affiliated investment vehicles.